Epidemiology of urinary tract infections and antibiotics sensitivity among pregnant women at Khartoum North Hospital.
BACKGROUND
Urinary tract infections (UTI) can lead to poor maternal and perinatal outcomes. Investigating epidemiology of UTI and antibiotics sensitivity among pregnant women is fundamental for care-givers and health planners.


METHODS
A cross sectional study has been conducted at Khartoum north teaching hospital Antenatal Care Clinic between February-June 2010, to investigate epidemiology of UTI and antibiotics resistance among pregnant women. Structured questionnaires were used to gather data from pregnant women. UTI was diagnosed using mid stream urine culture on standard culture media


RESULTS
Out of 235 pregnant women included, 66 (28.0%) were symptomatic and 169 (71.9%) asymptomatic. the prevalence of bacteriuria among symptomatic and asymptomatic pregnant women were (12.1%), and (14.7%) respectively, with no significant difference between the two groups (P = 0.596), and the overall prevalence of UTI was (14.0%). In multivariate analyses, age, gestational age, parity, and history of UTI in index pregnancy were not associated with bacteriuria. Escherichia coli (42.4%) and S. aureus (39.3%) were the commonest isolated bacteria. Four, 2, 2, 3, 4, 2 and 0 out of 14 E. coli isolates, showed resistance to amoxicillin, naladixic acid, nitrofurantoin, ciprofloxacin, co-trimoxazole, amoxicillin/clavulanate and norfloxacin, respectively.


CONCLUSIONS
Escherichia coli were the most prevalent causative organisms and showing multi drug resistance pattern, asymptomatic bacteriuria is more prevalent than symptomatic among pregnant women. Urine culture for screening and diagnosis purpose for all pregnant is recommended.
Faculty of Medicine, University of Khartoum, Khartoum, Sudan.
Hamdan Z
HZ
Hamdan
Abdel Haliem M
AH
Ziad
Salah K
SK
Ali
Ishag
I
Adam
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000145:classification / Q000187:drug effects* / Q000302:isolation & purification; D001424:Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D005260:Female; D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000382:microbiology; D013397:Sudan / Q000453:epidemiology; D011795:Surveys and Questionnaires; D014552:Urinary Tract Infections / Q000453:epidemiology* / Q000382:microbiology; D014556:Urine / Q000382:microbiology
D000900:Anti-Bacterial Agents
Afr J Reprod Health. 2005 Aug;9(2):118-24
16485592
Am J Med Sci. 1992 Mar;303(3):184-205
1595782
East Mediterr Health J. 2009 Jan-Feb;15(1):104-10
19469432
J Urol. 1984 Oct;132(4):697-700
6471216
Trop Doct. 1983 Jan;13(1):41-5
6836733
J Pak Med Assoc. 2010 Mar;60(3):213-6
20225781
J Egypt Public Health Assoc. 2007;82(3-4):203-18
18410708
Pharmacoepidemiol Drug Saf. 2004 Sep;13(9):645-52
15362088
Obstet Gynecol Clin North Am. 2001 Sep;28(3):581-91
11512502
J Matern Fetal Neonatal Med. 2009 Feb;22(2):124-8
19085630
Am J Obstet Gynecol. 2005 Feb;192(2):592-7
15696008
Expert Opin Pharmacother. 2001 May;2(5):813-8
11336624
Tanzan J Health Res. 2009 Jul;11(3):154-9
20734713
Br J Biomed Sci. 2006;63(3):109-12
17058709
J Infect Dev Ctries. 2007 Dec 01;1(3):263-8
19734603
Am Fam Physician. 2000 Feb 1;61(3):713-21
10695584
Diagn Microbiol Infect Dis. 2002 Nov;44(3):289-99
12493177
Med Sci Monit. 2009 Nov;15(11):PI61-5
19865064
J Antimicrob Chemother. 2003 Dec;52(6):1005-10
14613955
Infect Dis Clin North Am. 1997 Mar;11(1):13-26
9067782
Ethiop Med J. 2008 Jul;46(3):227-35
19271386
Clin Exp Obstet Gynecol. 2005;32(4):237-40
16440822
Scand J Infect Dis. 2005;37(4):262-8
15871165
Int J Antimicrob Agents. 2003 Jan;21(1):79-81
12507843
J Infect Dev Ctries. 2007 Dec 01;1(3):257-62
19734602
Int J Gynaecol Obstet. 2010 Aug;110(2):101-4
20417513